Navigation Links
Companion Diagnostics Market: Neurology & New Oncology Applications is Expected to Gain a Larger Share to 2019 Says a New Research Report Available at ReportsnReports.com
Date:9/9/2014

DALLAS, Sept. 9, 2014 /PRNewswire-iReach/ -- The global companion diagnostics market is expected to grow at a CAGR of 22.7% from 2014 to 2019. Factors such as rising need for personalized medicine in cancer treatment, growing adoption of companion diagnostics by the pharmaceutical industry, support from regulatory authorities, and emerging technologies such as next-generation sequencing (NGS) are expected to boost the global companion diagnostics market.

Photo - http://photos.prnewswire.com/prnh/20140909/144476

Among technologies, PCR is the most preferred test in the companion diagnostics market, which accounted for a share of 65.5% in 2014. This large share can be attributed to its ease of use, better results, faster turnaround time, and cost-effective solutions. The companion diagnostics market is expected to gain a larger market share in neurology and new oncology applications (leukemia, prostate cancer, and ovarian cancer) due to its efficient detection of biomarkers. Moreover, with the advancement in the bioinformatics field, NGS-based tests have the capability to target multiple genomes simultaneously and are likely to take over the existing technologies in the companion diagnostics market. The need for personalized medicine is increasing and it has gained importance in the research and medical centers, hospitals, and CROs. In the coming years, Asia is expected to be the key growth area in this market.

However, growth of this companion diagnostics market is hampered by the non-validated home brew tests that account for a large market share due to its low costs and minimal approval procedures. Moreover, uncertain reimbursement and coverage policies restrict the growth of the global companion diagnostic market, thus limiting the commercialization process.

Complete report is available at http://www.reportsnreports.com/reports/297416-companion-diagnostics-market-bytechnology-polymerase-chain-reaction-in-situ-hybridization-immunohistochemistry-application-breast-lung-cancer-by-end-user-pharmaceutical-companies-reference-lab-global-trends-forecasts-to-2019.html .

Reasons to Buy the Report

This companion diagnostics market report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios of the top players in the companion diagnostics market. The report analyzes the companion diagnostics market by technology, application, end-user, and geography
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the companion diagnostics market
  • Competitive Assessment: In-depth assessment of the market strategies, geographical and business segments, and product portfolios of the leading players in the companion diagnostics market
  • Market Development: Comprehensive information about the emerging markets. The report analyzes the market for various companion diagnostics tests/kits across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the companion diagnostics market

The major players in the global companion diagnostics market include Abbott Laboratories, Inc., Agilent Technologies, Inc., Biomérieux, Biogenex Laboratories, Danaher Corporation, Ge Healthcare, Myriad Genetics, Inc., Qiagen N.V., Roche Diagnostics, and Thermo Fisher Scientific, Inc. available for purchase at http://www.reportsnreports.com/Purchase.aspx?name=297416 .

Table of Contents for Companion Diagnostics Market by Technology (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry), Application (Breast, Lung cancer), & by End-user (Pharmaceutical Companies, Reference Lab)] - Global Trends & Forecasts to 2019 Research Report Cover:

1 Introduction

1.1 Objectives Of The Study

1.2 Markets Covered

1.3 Stakeholders

1.4 Market Scope

2 Research Methodology

2.1 Market Size Estimation

2.2 Market Share Estimation

3 Executive Summary

4 Premium Insights

5 Market Overview

5.1 Introduction

5.2 Evolution

5.3 Market Segmentation

5.4 Market Dynamics

6 Industry Trends

6.1 Porter's Five Forces Analysis

6.2 Strategic Benchmarking

7 Global Companion Diagnostics Market, By Applications

7.1 Introduction

7.2 Breast Cancer

7.3 Lung Cancer

7.4 Colorectal Cancer

7.5 Melanoma

7.6 Gastric Cancer

7.7 Other Indications (Prostate, Ovarian, Leukemia, Infectious Disease & Neurology)

8 Global Companion Diagnostics Market, By Technology

8.1 Introduction

8.2 Polymerase Chain Reaction (PCR)

8.3 In Situ Hybridization (ISH)

8.4 Immunohistochemistry (IHC)

8.5 Other Technologies (NGS,Multiplex Assay, Cellular Immune Testing, Mab)

9 Market, By End User

9.1 Introduction

9.2 Pharmaceutical Companies

9.3 Reference Lab

9.4 Others (Cro, Physicians, Hospitals & Academic Medical Centers)

10 Global Companion Diagnostics Market, By Geography

10.1 Introduction

10.2 North America

10.3 Europe

10.4 Asia

10.5 Rest Of The W0rld

11 Competitive Landscape

11.1 Overview

11.2 Agreements, Partnerships & Collaborations

11.3 Merger And Acquisitions

11.4 New Product Launches

11.5 Expansion

12 Company Profiles

12.1 Introduction

12.2 Abbott Laboratories, Inc.

12.3 Agilent Technologies, Inc.

12.4 Biomérieux

12.5 Biogenex Laboratories

12.6 Danaher Corporation

12.7 Ge Healthcare

12.8 Myriad Genetics, Inc.

12.9 Qiagen N.V.

12.10 Roche Diagnostics

12.11 Thermo Fisher Scientific, Inc.

Priced at US$ 4650 for  a single user PDF license, request a discount on this research at http://www.reportsnreports.com/contacts/Discount.aspx?name=297416 .

About Us: 

ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets. This comprehensive collection of market research reports include market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. Our research specialists & industry experts, through our market research offerings, ensure we deliver on all your business & industry research requirements - first time and every time! (http://www.reportsnreports.com/ ).

Media Contact: Priyank Tiwari, ReportsnReports, +1 888 391 5441, sales@reportsandreports.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE ReportsnReports
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
2. Companion Diagnostics and Personalized Medicine Market Report 2012: Twease.org
3. Life Technologies to Partner with Bristol-Myers Squibb for Companion Diagnostics Development
4. Eutropics Pharmaceuticals awarded NCI contract to develop companion diagnostic for guiding AML treatments
5. Eutropics Pharmaceuticals signs $1.5M NCI/SBIR contract to develop companion diagnostic for guiding Multiple Myeloma treatments
6. Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes
7. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
8. The Complete Guide to Companion Diagnostics: Market Environment Products and Companies
9. Perrigo Company To Acquire OTC Companion Animal Health Company, Velcera, Inc., For $160 Million
10. Frost & Sullivan Recognizes ResearchDx for Its Impressive Performance in the Companion Diagnostics Sector
11. QIAGEN Enters Into Broad Collaboration Agreement With Lilly for the Development and Commercialization of Companion Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... HOUSTON (PRWEB) , ... October 08, 2019 , ... ... compliance (GRC) software as a service (SaaS) platform, today announced integration between the ... reduces the average time it takes medical office staff to obtain peer references ...
(Date:10/8/2019)... ... October 08, 2019 , ... STACS DNA, the sample-tracking ... sexual assault evidence collection kit (SAECK) tracking system. Led by the Executive Office of ... the system is to be implemented in all regions of the state by the ...
(Date:10/8/2019)... ... October 07, 2019 , ... ... Research Institute in a strategic merger to form Apex Innovative Sciences, Inc., an ... central nervous system indications. In the three-company M&A transaction, Apex acquired Clinical Trial ...
Breaking Medicine Technology:
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... What unique ... and future state of aging and wellness in the nation? That question will be ... Active Aging Conference, Leadership Summit and Expo. The event will take place October 10-12, ...
(Date:10/8/2019)... CA (PRWEB) , ... October 08, 2019 , ... Dr. ... gum disease in San Jose, CA experience relief from this common and treatable condition. ... in order to save adults from living with uncomfortable symptoms, including tender and bleeding ...
(Date:10/8/2019)... ... October 08, 2019 , ... As ... samples, Meiqing Shi, associate professor with the University of Maryland Department of Veterinary ... published in Nature Communications, Shi and his lab have discovered a new pathway ...
(Date:10/8/2019)... ... October 08, 2019 , ... At the 13th ... President Gregg Church will inform conference attendees how the 4medica Perfect ... starting with the right, clean patient data. The single platform interfaces to core ...
(Date:10/8/2019)... ... October 08, 2019 , ... The University of California San ... Awards 1st Round (Top Ten) Finalist in its Best Cardiovascular Digital Diagnostic category. ... promote faster, better, more cost-effective healthcare by improving outcomes such as shorter hospital ...
Breaking Medicine News(10 mins):